Synchrotron Imaging Informs Customized Cochlear Implant Programming
The maps the research team created using the synchrotron could make a huge difference to the sound quality of cochlear implants.
The maps the research team created using the synchrotron could make a huge difference to the sound quality of cochlear implants.
Envoy Medical has been awarded another patent which it has secured as part of its implantable hearing devices technology portfolio.
Children born with severe hearing impairment underwent cochlear implant surgery, performed by a team of ENT's at Goa Hospital.
Under the theme “What does sound mean to you?” four professional artists have created designs that will form limited-edition covers for the MED-EL hearing implant audio processors.
Read MoreForeword Publicity announced the release of “Mickey on the Move Farming,” written by Michelle Wagner, the second book in the “Mickey on the Move” series. Both tales juxtapose information on hearing loss technology and implants in kids with the emphasis that Mickey is leading his best life.
Read MoreEnvoy Medical Corporation, a hearing health company focused on providing innovative technologies across the hearing loss spectrum, announced the US Food and Drug Administration (FDA) approved its Investigational Device Exemption (IDE) application to begin a clinical trial with its fully implanted Acclaim cochlear implant.
Read MoreLast year, Ferrigno spoke with ACI Alliance Executive Director Donna Sorkin about his experience since receiving a CI (see video in story), sharing his perspectives about overcoming challenges throughout his life. During the Opening Session of CI2022 DC they will continue that conversation.
Read MoreAuditory Insight, a consultancy for the hearing healthcare industry, analyzes patients’ concerns with cochlear implants and identifies three causative barriers in its Q1 2022 Research Note.
Read MoreUniversity Hospitals Cleveland Medical Center and UH Rainbow Babies and Children’s Hospital are participating in a Cochlear Americas’-sponsored clinical trial for an implantable hearing device in children 5 to 11 years of age who have been born with hearing loss that may be caused by craniofacial abnormalities.
Read MorePodcaster Richard Pocker announced the availability of a book of the transcripts of 25 interviews form his website, cochlearimplantbasics.com
Read MoreCochlear implants are already FDA approved for those with moderate-to-profound bilateral sensorineural hearing loss. With this approval, Cochlear can expand implantable treatment options for those with UHL/SSD to include cochlear implants, for the first time, according to its announcement.
Read MoreWhile uncertainties still exist, the company announced that it believes it has now identified the root cause of the issue, which is related to the manufacturing process and not the design of the implants. The company is currently working on implementing and verifying a solution to the issue to ensure high and consistent process quality, according to its latest announcement.
Read MoreTo overcome the obstacles current CIs might cause during surgery, researchers at the Hamlyn Centre proposed a novel functional atraumatic self-shaping cochlear implant. It is a pre-curved CI that curls into the cochlea under the influence of body temperature.
Read MoreAdvanced Bionics announced that it has been recognized with a Hearing Technology Innovator Award for its SKY CI M sound processor by Hearing Health & Technology Matters for its technological innovation and achievement in the hearing industry.
Read MoreOticon Medical, which constitutes the hearing implants business in the Demant Group, announced that it has decided to take voluntary field corrective action by recalling non-implanted Oticon Medical Neuro Zti implants and to temporarily halt sales of new implants. The recall is entirely related to the identification of performance issues in a small subset of implants, and there have been no reported safety events with the implants, according to the company’s announcement.
Read MoreCochlear Limited (ASX: COH) announced that it has obtained Food and Drug Administration (FDA) approval and clearance in the last month for its Cochlear Remote Assist solution in the Nucleus and Baha Systems.
Read MoreA new, thumb-sized device from iotaMotion called iotaSoft intended to help place cochlear implants into patient’s ears, received De Novo clearance from the Food and Drug Administration (FDA), according to an article in “Fierce Biotech.”
Read MoreGeorge Cire, Chris James, and Paula Greenham review the major treatment modalities, the general indications for implant use and referral, and present a picture of current clinical practice as reflected in Cochlear Ltd’s Implant Recipient Observational Study (IROS).
Read More